Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
Nurse reported the day after the last dose experiencing pain in her right clavicle; Nurse reported the day after the last dose experienced enlarged lymph nodes; This spontaneous report was received from a nurse and refers to herself, a female patient of an unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the first, second and third dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) administered for prophylaxis (strength, exact quantity volume, lot #, expiration date, route and anatomical site of administration were not reported). On an unknown date, the day after the last dose, the patient experiencing pain in her right clavicle (Pain) and enlarged lymph nodes. The patient also reported that her daughter also received this vaccine and did not experience any symptoms. At the reporting time, the patient recovered from the events. The causal relationship between the events and Human Papillomavirus 9-valent Vaccine, Recombinant was not provided.